ABSTRACT The B-cell alloantigens of an HLA-DR3-homozygous, MB2-homozygous, MT2-positive lymphoblastoid cell line were studied by two-dimensional gel electrophoresis. Analysis of gel patterns suggested assignment of the-HLA-DR3 determinant to the larger (35,000-dalton) subunit (a) of the B-cell alloantigen. MB2 was found to be either a determinant on the small (27,000 dalton) subunit (fi) or a crossreactive determinants) on the HLA-DR3 a subunit and an additional a subunit. MT2 was found to be a determinant on Ia antigen-like molecules distinct from those carrying the MB and HLA-DR determinants. The results are consistent with the existence in the major histocompatibility complex of at least three loci encoding B-cell alloantigens.
on the HLA-DR3 a subunit and an additional a subunit. MT2 was found to be a determinant on Ia antigen-like molecules distinct from those carrying the MB and HLA-DR determinants. The results are consistent with the existence in the major histocompatibility complex of at least three loci encoding B-cell alloantigens.
HLA-DR, a locus in the human major histocompatibility complex (MHC) (1) , codes for polymorphic cell surface glycoproteins present on B lymphocytes, macrophages, and certain other populations of cells (2) (3) (4) (5) . The HLA-DR antigens (DRs) are composed of two noncovalently associated glycoproteins of 35,000 daltons (a) and 27,000 daltons (,B) as determined by sodium dodecyl sulfate/polyacrylamide gel electrophoresis (3, 6, 7) . The two subunits show marked differences in NH2-terminal amino acid sequence (7) and isoelectric point (7) (8) (9) .
After serological analysis of data from the Seventh International Histocompatibility Workshop, Duquesnoy et al. (10) proposed a second B-cell alloantigen system, MB. MB is thought to be a gene closely linked to HLA-DR although it is possible that it encodes public specificities of DRs. The specificity MB1 is closely associated with DR1, DR2, and DRw6; MB2, with DR3 and DR7; and MB3, with DR4 and DR5 (10) .
In the Eighth International Histocompatibility Testing Workshop, three supertypic, presumably crossreactive, specificities were discussed (11, 12) . These antigens were designated MT1, MT2, and MT3. MT1 is found in association with DRI, DR2, DRw6, and DRw1O; MT2, with DR3, DR5, DRw6, and DRw8; and MT3, with DR4, DR7, and DRw9 (11) . These specificities may be determinants present on the molecule carrying the DR determinants or on products distinct from DR.
Murine Ta antigens encoded in the I region of H-2 are analogous to human DR antigens. Recently Jones et al. (13) and others (14-16) have documented two-gene control of expression of certain Ia antigens. These investigators have shown that Ia antigens precipitated by antisera directed against certain I-E/C haplotypes are composed of an a subunit encoded in the I-E/C region and a ( subunit encoded in the I-A region.
At present in the human, it is not known how many loci code for B-cell alloantigens nor is it known whether genes in the MHC code for one or both of the subunits of B-cell alloantigens.
We have investigated the molecular relationships of DR, MB, and MT antigens by immune precipitation and two-dimensional electrophoretic techniques, using a lymphoblastoid cell line homozygous for HLA-DR3 and MB2 and positive for MT2 and a combination of a chimpanzee antiserum and alloantisera specific for these three products. MAX (7w101) is a human alloantiserum (19) produced by immunization of a father (A2, B8, C-, DRw6, Dw6, MBJ/A3, B7, C-, DR2, Dw2, MB1) against his son's lymphocytes (A2, B8, C-, DRw6, Dw6, MBJ/Auv31, B14, C-, DR7, Dw7, MB2). MAX has strong reactivities against DR7 and MB2 and a weak reactivity against Aw3l; the activity against Aw3l is removed by absorption of the antiserum with the son's platelets. Our laboratory uses MAX (after absorbtion with Aw31-positive platelets and with DR7-positive MB2-negative DAW cells) to define MB2. This specificity was formerly designated DuB 33. Similar reaction patterns are given by the MB2 serum 7w127 (20) . A somewhat longer MB2 pattern has been described by Duquesnoy et al. (10) . Because the Pala cell line used in all studies
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Abbreviations: MHC, major histocompatibility complex; DR, HLA-DR .-ntigen; a, 35,000-dalton subunit of HLA-DR; (3, 27 ,000-dalton subunit of HLA-DR. (21) and then solubilized in 0.1% octaethylene glycol dodecyl ether (Nikkol) in Tris-buffered saline prior to centrifugation at 100,000 X g for 90 min. Phenylmethylsulfonyl fluoride was added to 0.5 mM and tosyllysine chloromethyl ketone was added to 0.1 mM at the beginning of membrane purification.
Immunoprecipitation. Immunoprecipitations were performed after preprecipitations with normal rabbit serum as described (22) . Formalin-fixed heat-killed Staphylococcus aureus strain Cowan I (23) was used to bind the immune complexes and precipitate them from the detergent-solubilized membrane preparation (22) . The S. aureus-antibody-antigen pellets were washed three times with 2% gamma globulin-free fetal calf serum in 0.05% octaethylene glycol dodecyl ether in Tris-buffered saline and then twice in water. Antigen and antibody were dissociated from the S. aureus pellet by incubation for 30 min at 250C in lysis buffer A of O'Farrell (24) .
Two-Dimensional Electrophoresis. The sample was analyzed with the two-dimensional gel electrophoresis system of O'Farrell (24) . Gels of pH range 5-7 or 5-8 were used. For the latter, 5/7 Ampholines (Bio-Rad) and 3/10 Ampholines were used in a 1:1 ratio. All other conditions were identical to those described by O'Farrell (24) . The sodium dodecyl sulfate/ polyacrylamide gels were all 10.5% (wt/vol) in acrylamide for the second dimension. All gels were developed by the fluorographic method of Bonner and Laskey (25) .
RESULTS
Various antisera were used to precipitate B-cell alloantigens from the detergent-solubilized Pala membrane preparation. The antisera JIMOH, JIMOH/Swei, MAX, and IA172 all gave simple patterns on two-dimensional gel electrophoresis. In each case there was a series of spots at the acidic end of the gel which corresponded to the a subunit. At the basic end of the gel, there was a series of spots of higher electrophoretic mobility, corresponding to the # subunit.
Analysis of the ft Subunits. Gels at pH 5-8 were run to examine the basic subunits. In the JIMOH/Swei precipitate (Fig. IA) , the (3subunit appeared to be a doublet. This usually is the case for MAX precipitates (Fig. 2C) . When the MAX and JIMOH/Swei precipitates were run together on one gel, the subunits superimposed (Fig. iC) Fig. 1D ) is identical to the subunit of Fig. 1 A and B. The middle spot appears to be three molecules of the same isoelectric point but different molecular weights. This effect was also observed for some a subunit spots (see below). The: subunit pattern obtained with serum IA172 (Fig. 1E ) was similar to that of JIMOH. The # subunits precipitated by IA172 have been shown to be identical to those precipitated by JIMOH (Fig. 1D ) by running both precipitates on the same gel and finding that the dots superimpose (data not shown). The # spots present in the JIMOH and IA172 gels and not present in the JIMOH/Swei or MAX precipitates are assumed to be the result of anti-MT2 antibodies present in JIMOH and IA172 and absent in JIMOH/Swei and MAX. We consider these to be MT2-specific # subunits (diagonal arrows, Fig. 1) .
Analysis of the a Subunits. Gels with a pH gradient of 5 to 7 were used to examine the a subunit. The JIMOH/Swei (anti-DR3) pattern was the most simple ( Fig. 2A) , with three a subunit spots (diagonal arrows). They are a subset of the spots precipitated by JIMOH (Fig. 2B) and IA172 (Fig. 1E) 40 ,ul of MAX (anti-MB2) (C). All samples were applied to two-dimensional gels of pH 5-7. Orientation of gels was the same as in Fig. 1 (Fig. 2C) . These appeared to be MT2-specific a subunits. The more acidic of these two MT2-specific a spots appeared to be several molecules of the same isoelectric point but different molecular weights.
The MAX (anti-MB2) pattern of a subunits contained two sets of spots (Fig. 2C) . One set was identical to that in the JIMOH/Swei pattern in Fig. 2A . The other set of three spots (vertical arrows, Fig. 2C ) was not seen in the JIMOH/Swei or JIMOH pattern. These we consider to be MB2-specific a subunits.
If MAX (anti-MB2) and JIMOH/Swei (anti-DR3) do indeed precipitate the same subunit, then on the cell surface both sets of a subunits precipitated by MAX must be found in combination with the same (3subunit, shown by the vertical arrow in Fig. 1 . Thus, the anti-DR3 antibodies of JIMOH/Swei presumably must be directed against the a subunit of the HLA-DR3 complex ( Fig. 2A) Fig. 1B ) or (ii) are crossreactive determinants on the two sets of a subunits shown in Fig. 2B . In either case a gene coding for MB determinants exists which is distinct from HLA-DR. The first possibility is analogous to the situation with murine Ia antigens in which a gene in the I-A region encodes the subunit and a gene in the I-E/C region encodes the a subunit (13) .
The additional a and subunits precipitated by JIMOH and IA172 are distinct from the DR3 and MB2 molecules. They appear to be separate molecules bearing MT2 determinants. We do not know which subunit, a or carries the MT2 determinant but, again, the results suggest that a separate gene must code for MT2 determinants.
DISCUSSION
The data presented provide for the presence on one cell of a minimum of five components of human Ia-like antigens, each of which may be a product of a separate gene. This minimum is based upon the assumption that posttranslational variability, such as differential sialic acid content (26) , is responsible for the presence of "sets" of spots. These Ia-like antigen components include three a subunits: one MT2-associated, one MB2-associated, and one which is DR3-associated and possibly crossreactive with MB2 antibodies (diagonal arrows, Fig. 2A ). In addition there are a minimum of two ( subunits: one MT2-associated and one shared by the DR3 and MB2 antigens. At least three of these five components-the HLA-DR product, the MB product, and the MT product-are coded for by MHC-linked loci. HLA-DR maps near HLA-D in the MHC (1) . MB2, as defined by MAX/DAW and 7w127, has been shown in family studies to segregate with HLA (20) . MT2, as defined by IA172, also segregates with HLA in families (27, 28) . Because the Pala cell line used is homozygous for HLA-DR3 and MB2 and is positive for MT2, a minimum of three independent loci coding for Ia-antigen-like determinants can be assigned to the human MHC.
If we are correct in our interpretation that the ( Fig. 2C ). Thus, we have two genes linked to HLA which contribute to the structure of a single B-cell alloantigen, the DR3-positive and MB2-positive antigen seen in Fig. 2A .
If the DR3 and MB2 ,B subunits are not identical but merely have the same molecular weight, isoelectric point, and tendency to periodic detection as a doublet, then we cannot assign DR3 determinants to the a subunit. In this case the minimum number of Ia antigen-like components on one cell type has to be raised to six, now including three (3 chains-the DR3-associated ( chain, the MB2-associated ( chain, and the MT2-specific , chain. A definitive answer on this point will only come from peptide mapping or sequencing of the ,B chains.
From our data we cannot determine whether the a or( chain of the MT2 antigen carries the MT2 determinant. MT2 is presumably expressed on one or more of the 3 spots (diagonal arrows, Fig. 1D ) or a spots (arrowheads, Fig. 2B ) unique to the JIMOH gels. Tosi et al. (29) found the MT1 (DC-1) (30) and DRw6 determinants to be on separate molecules. In binding studies, MT1 was localized to the 13 subunit. Our results are similar to theirs in that MT2 determinants are found on molecules separate from those containing the DR3 determinant. Conceivably, some of the a and 1 spots precipitated by JIMOH but not by JIMOH/Swei (anti-DR3) may be derived from DR-like antigens currently undefined by serology.
Examination of Fig. 1E indicates that IA172 does precipitate DR3 in addition to MT2-specific subunits. This may be a result of crossreactivity of DR3 with the anti-DR5 or anti-DRw6 antibodies potentially present in the serum or, alternatively, MT2 and DR3 may themselves be crossreactive.
Several research groups have suggested that the DR allospecificities reside on the small (27,000 daltons) subunit of B-cell alloantigens. These groups have pointed to the binding of alloantisera to isolated (3subunits (29) and to the high variability of (3 subunit tryptic fragments (31) . Two-dimensional gel electrophoresis has shown variable patterns for the (3sub- (9, 32) . From binding studies and analysis of a and : tryptic fragments Klareskog et al. (33) came to the contradictory conclusion that the HLA-DR determinant is on the a subunit, a conclusion supported by our data. The DR3 determinant of Pala similarly may reside on the a subunit. The two opposing points of view could be reconciled if some DR specificities were hybrid determinants formed by close association of a and /3 subunits. Some antisera might have predominantly antibodies to the a-subunit portion and others, to the /3-subunit portion, causing difficulties in interpretation when measuring binding to isolated subunits.
Our two-dimensional gel electrophoresis patterns are similar to those of B-cell alloantigens published by others (9, 32 (34) . We have used nonequilibrium pH gradient electrophoresis on DR of several cell lines and never have found such a spot. Shackelford and Strominger (9) found that detergent washing of the precipitated DR resulted in removal of one of their basic invariant spots (MI). Our washings are quite vigorous and may explain this discrepancy.
Our studies were greatly aided by the availability of the MB2-specific human alloantiserum MAX. As can be seen by comparing Fig. 2 C and B , the MAX serum precipitates the MB2-specific a subunit which is not precipitated by the chimpanzee serum JIMOH. A rabbit anti-DR xenoantiserum used in our laboratory (JHSB) (3) also did not precipitate the MB2-specific a subunit (data not shown). Other investigators using xenoantisera therefore may have found-less heterogeneity of the a subunit than actually is present.
